Why Clorox (CLX) Stock Is Up Today

Clorox (CLX) is up 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear same-day catalyst is not obvious, so the move appears to be tied to a mix of company execution updates and a broader bid for defensive consumer staples shares. This could be because investors are giving more credit to Clorox’s restructuring plan, its expanded portfolio after the GOJO acquisition, and the steadier earnings profile that household-products names can offer when the market rotates away from higher-volatility groups.

Details:

Clorox said on June 17 that it is moving to a simplified operating structure meant to streamline leadership oversight, focus resources on stronger growth areas, and support faster execution.

In third-quarter fiscal 2026 results released April 30, Clorox posted flat sales but higher adjusted EPS, and it kept emphasizing cost savings, productivity work, and integration of GOJO and the Purell brand.

The company completed the GOJO acquisition on April 1, giving Clorox a larger presence in health and hygiene products and adding another avenue for longer-term growth.

Recent market coverage has shown investors rotating toward defensive sectors such as consumer staples during periods of weakness in technology and other riskier areas, which likely helped CLX as well.

Sources:

SEC, The Clorox Company, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLX Insider Trading Activity

$CLX insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:

PIERRE R BREBER purchased 5,000 shares for an estimated $429,124

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CLX Hedge Fund Activity

We have seen 500 institutional investors add shares of $CLX stock to their portfolio, and 402 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

POINT72 ASSET MANAGEMENT, L.P. added 1,234,932 shares (+345.6%) to their portfolio in Q1 2026, for an estimated $124,672,560
TWO SIGMA INVESTMENTS, LP removed 929,055 shares (-88.2%) from their portfolio in Q1 2026, for an estimated $93,792,747
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 892,381 shares (-55.1%) from their portfolio in Q1 2026, for an estimated $90,090,323
FMR LLC added 822,022 shares (+127.0%) to their portfolio in Q1 2026, for an estimated $82,987,231
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 738,417 shares (-98.5%) from their portfolio in Q1 2026, for an estimated $74,546,888
AQR CAPITAL MANAGEMENT LLC added 589,873 shares (+122.9%) to their portfolio in Q1 2026, for an estimated $59,550,628
QUBE RESEARCH & TECHNOLOGIES LTD removed 458,337 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $46,271,411

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CLX Congressional Stock Trading

Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CLX Price Targets

Multiple analysts have issued price targets for $CLX recently. We have seen 9 analysts offer price targets for $CLX in the last 6 months, with a median target of $97.0.

Here are some recent targets:

Chris Carey from Wells Fargo set a target price of $95.0 on 05/18/2026
Lauren Lieberman from Barclays set a target price of $85.0 on 05/04/2026
Javier Escalante from Evercore ISI Group set a target price of $110.0 on 05/01/2026
Andrea Teixeira from JP Morgan set a target price of $95.0 on 05/01/2026
Filippo Falorni from Citigroup set a target price of $97.0 on 05/01/2026
Peter Grom from UBS set a target price of $96.0 on 05/01/2026
Dara Mohsenian from Morgan Stanley set a target price of $110.0 on 04/23/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.